As of 2025-05-23, the Relative Valuation of Surmodics Inc (SRDX) is (44.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.16 USD, the upside of Surmodics Inc based on Relative Valuation is -253.8%.
The range of the Relative Valuation is (36.58) - (44.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.3x - 35.0x | 33.6x |
| Forward P/E multiples | 26.2x - 31.8x | 31.0x |
| Fair Price | (36.58) - (44.26) | (44.86) |
| Upside | -225.5% - -251.8% | -253.8% |
| Date | P/E |
| 2025-05-21 | -20.91 |
| 2025-05-20 | -21.35 |
| 2025-05-19 | -21.21 |
| 2025-05-16 | -20.56 |
| 2025-05-15 | -20.17 |
| 2025-05-14 | -20.09 |
| 2025-05-13 | -20.01 |
| 2025-05-12 | -19.49 |
| 2025-05-09 | -19.25 |
| 2025-05-08 | -19.58 |
| 2025-05-07 | -19.54 |
| 2025-05-06 | -19.69 |
| 2025-05-05 | -19.40 |
| 2025-05-02 | -19.88 |
| 2025-05-01 | -20.04 |
| 2025-04-30 | -20.15 |
| 2025-04-29 | -22.25 |
| 2025-04-28 | -22.37 |
| 2025-04-25 | -21.19 |
| 2025-04-24 | -21.15 |
| 2025-04-23 | -20.58 |
| 2025-04-22 | -20.58 |
| 2025-04-21 | -20.54 |
| 2025-04-17 | -19.83 |
| 2025-04-16 | -20.24 |
| 2025-04-15 | -20.39 |
| 2025-04-14 | -20.46 |
| 2025-04-11 | -20.50 |
| 2025-04-10 | -19.60 |
| 2025-04-09 | -20.32 |
| 2025-04-08 | -19.68 |
| 2025-04-07 | -20.50 |
| 2025-04-04 | -21.09 |
| 2025-04-03 | -21.66 |
| 2025-04-02 | -22.13 |
| 2025-04-01 | -22.22 |
| 2025-03-31 | -21.96 |
| 2025-03-28 | -22.12 |
| 2025-03-27 | -22.02 |
| 2025-03-26 | -21.93 |
| 2025-03-25 | -22.24 |
| 2025-03-24 | -21.89 |
| 2025-03-21 | -21.86 |
| 2025-03-20 | -21.57 |
| 2025-03-19 | -21.58 |
| 2025-03-18 | -21.13 |
| 2025-03-17 | -20.87 |
| 2025-03-14 | -20.36 |
| 2025-03-13 | -20.37 |
| 2025-03-12 | -19.22 |